{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T05:20:24Z","timestamp":1722921624966},"reference-count":20,"publisher":"Japanese Society for the Study of Xenobiotics","issue":"5","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2003]]},"DOI":"10.2133\/dmpk.18.296","type":"journal-article","created":{"date-parts":[[2004,12,7]],"date-time":"2004-12-07T06:15:22Z","timestamp":1102400122000},"page":"296-302","source":"Crossref","is-referenced-by-count":5,"title":["Application of the PKCYP Test to Predict Caffeine Clearance Mediated by CYP1A2 in a Rat Acute Liver Injury Model"],"prefix":"10.2133","volume":"18","author":[{"given":"Noriko","family":"Kose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minae","family":"Isawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Kizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Takanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emi","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"900","reference":[{"key":"10.2133\/dmpk.18.296_bb0005","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0300-483X(02)00492-4","article-title":"Polymorphism of cytochrome P450 and xenobiotic toxicity","volume":"181\u2013182","author":"Ingelman\u00adSundberg","year":"2002","journal-title":"Toxicology"},{"key":"10.2133\/dmpk.18.296_bb0010","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0169-409X(02)00077-7","article-title":"Pharmacogenomics of organic anion\u00adtransporting polypeptides (OATP)","volume":"54","author":"Tirona","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.2133\/dmpk.18.296_bb0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/sj.tpj.6500001","article-title":"Polymorphisms in the ABC drug transporter gene MDR1","volume":"1","author":"Brinkmann","year":"2001","journal-title":"Pharmacogenomics"},{"key":"10.2133\/dmpk.18.296_bb0020","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/ajhp\/59.21.2061","article-title":"Genetic basis of drug metabolism","volume":"21","author":"Ma","year":"2002","journal-title":"Am. J. H ealth. Syst. Pharm."},{"key":"10.2133\/dmpk.18.296_bb0025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00008571-200004000-00001","article-title":"Phenotyping of drug\u00admetabolizing enzymes in adults: a review of in\u00advivo cytochrome P450 phenotyping probes","volume":"10","author":"Streetman","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.2133\/dmpk.18.296_bb0030","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3109\/03602539308993982","article-title":"In vitro methods for assessing human hepatic drug metabolism: their use in drug development","volume":"25","author":"Wrighton","year":"1993","journal-title":"Drug Metab. Rev."},{"key":"10.2133\/dmpk.18.296_bb0035","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/0006-2952(94)90520-7","article-title":"Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance","volume":"47","author":"Houston","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.2133\/dmpk.18.296_bb0040","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0163-7258(96)00184-2","article-title":"Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data","volume":"73","author":"Iwatsubo","year":"1997","journal-title":"Pharmacol. Ther."},{"key":"10.2133\/dmpk.18.296_bb0045","first-page":"1350","article-title":"Prediction of human clearance of twentynine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half\u00adlife approach and nonspecific binding to microsomes","volume":"27","author":"Obach","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.2133\/dmpk.18.296_bb0050","doi-asserted-by":"crossref","first-page":"492","DOI":"10.5649\/jjphcs1975.26.492","article-title":"A simplified diagnostic approach for estimating in vivo hepatic drug clearance; its preliminary application for the drug caffeine, using CYP1A probe in a rat model","volume":"26","author":"Matsunaga","year":"2000","journal-title":"Jpn. J. Hosp. Pharm."},{"key":"10.2133\/dmpk.18.296_bb0055","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1248\/bpb.24.1037","article-title":"Application of the PKCYP\u00adtest in cases of altered CYP1A2 for multiple CYP systems in rat models of disease","volume":"24","author":"Matsunaga","year":"2001","journal-title":"Biol. Pharm. Bull."},{"key":"10.2133\/dmpk.18.296_bb0060","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1248\/bpb.24.1305","article-title":"Application of the PKCYP\u00adtest to predict the amount of in vivo CYP2C11 using tolbutamide as a probe","volume":"24","author":"Matsunaga","year":"2001","journal-title":"Biol. Pharm. Bull."},{"key":"10.2133\/dmpk.18.296_bb0065","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2133\/dmpk.17.190","article-title":"Simultaneous assessment of the in vivo amount of CYP1A2 and CYP3A2 by the PKCYP\u00adtest using theophylline in rats","volume":"17","author":"Matsunaga","year":"2002","journal-title":"Drug Metabol. Pharmacokin."},{"key":"10.2133\/dmpk.18.296_bb0070","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1139\/y00-066","article-title":"Differential alteration of cytochrome P450 isoenzymes in two experimental models of cirrhosis","volume":"78","author":"Bastien","year":"2000","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.2133\/dmpk.18.296_bb0075","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/15287399509532017","article-title":"Characterization of benzo[a]pyrene metabolism and related cytochrome P\u00ad450 isozymes in Syrian hamster livers","volume":"46","author":"Sun","year":"1995","journal-title":"J. Toxicol Environ. Health"},{"key":"10.2133\/dmpk.18.296_bb0080","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0006-2952(90)90051-L","article-title":"Aflatoxin B1\u00adspecific cytochrome P\u00ad450 isosyme (P\u00ad450\u00adAFB) inducible by 3\u00admethylcholanthrene in golden hamsters","volume":"39","author":"Fukuhara","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"10.2133\/dmpk.18.296_bb0085","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/oxfordjournals.jbchem.a122840","article-title":"Characterization of three forms of cytochrome P\u00ad450 inducible by 3\u00ad methylcholanthrene in Golden hamster livers with special reference to aflatoxin B1 activation","volume":"106","author":"Fukuhara","year":"1989","journal-title":"J. Biochem. (Tokyo)"},{"key":"10.2133\/dmpk.18.296_bb0090","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.2042-7158.1983.tb04256.x","article-title":"Moment analysis for disposition kinetics of several cephalosporin antibiotics in rats","volume":"35","author":"Yamaoka","year":"1983","journal-title":"J. Pharm. Pharmacol."},{"key":"10.2133\/dmpk.18.296_bb0095","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3109\/00498259509061911","article-title":"Changes in the metabolism of three model substrates catalysed by different P450 isozyme when administered as a cocktail to the carbon tetrachloride\u00adintoxicated rat","volume":"25","author":"Tanaka","year":"1995","journal-title":"Xenobiotica."},{"key":"10.2133\/dmpk.18.296_bb0100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/jps.2600760104","article-title":"Effects of fasting on biperiden pharmacokinetics in the rat","volume":"76","author":"Nakashima","year":"1987","journal-title":"J. Pharm. Sci."}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S134743671530896X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S134743671530896X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T14:35:24Z","timestamp":1586010924000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S134743671530896X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003]]}},"alternative-id":["S134743671530896X"],"URL":"https:\/\/doi.org\/10.2133\/dmpk.18.296","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2003]]}}}